U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT06841510) titled 'Efficacy and Safety of GENOSS SES in Patients with Coronary Artery Disease' on Feb. 17.
Brief Summary: Efficacy and Safety of GENOSS SES in patients with coronary artery disease
Study Start Date: April 19, 2018
Study Type: OBSERVATIONAL
Condition:
Coronary Arterial Disease (CAD)
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: Genoss Co., Ltd.
Disclaimer: Curated by HT Syndication....